Research Database

29 studies found

Positive

69.0%

Negative

10.3%

Inconclusive

20.7%

Page 1 of 2

PositiveAnimal Study -

Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease

2023

Graft-versus-Host-DiseaseInflammationOrgan Transplant Failure

PositiveReview/Other

Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease

2021

Graft-versus-Host-Disease

PositiveReview/Other

Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response

2021

Cancer - Leukemia

InconclusiveReview/Other

Marijuana Use Among Adult Liver Transplant Candidates and Recipients

2021

Addiction

PositiveAnimal Study -

A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo

2021

Organ Transplant Failure

PositiveReview/Other

The Impact of Marijuana Use on Liver Transplant Recipients: A 900 Patient Single Center Experience

2021

Liver Failure

InconclusiveMeta-analysis -

Epidemiology of cannabis use and associated outcomes among kidney transplant recipients: A meta-analysis

2021

Kidney Failure

PositiveReview/Other

P-NGAL Day 1 predicts early but not one year graft function following deceased donor kidney transplantation - The CONTEXT study

2020

Organ Transplant Failure

InconclusiveReview/Other

Marijuana use should not preclude consideration for kidney transplantation

2019

Kidney Failure

PositiveAnimal Study -

Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation

2019

Inflammation

NegativeAnimal Study - Veterinary Clinical Trial

Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes

2019

Addiction - Cannabis

InconclusiveReview/Other

Influence of history of cannabis smoking in selected donors on the outcomes of lung transplantation

2017

Cannabis Adverse Effects

PositiveReview/Other

Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges.

2017

Arthritis - Rheumatoid

NegativeReview/Other

High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana

2016

Organ Transplant Failure

PositiveReview/Other

A CB2-Selective Cannabinoid Suppresses T-cell Activities and Increases Tregs and IL-10

2016

Organ Transplant Failure

PositiveReview/Other

Cannabis - the Israeli perspective

2016

Anorexia

PositiveAnimal Study - Veterinary Clinical Trial

Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation.

2016

Cardiovascular Diseases (CVD)

PositiveReview/Other

Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.

2015

Inflammation

PositiveReview/Other

Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury.

2015

Liver Failure

PositiveReview/Other

Effects of Cannabinoids on T-cell Function and Resistance to Infection.

2015

Arthritis

Command Palette

Research Database

Anandamide reduces the migration of lymphocytes to the intestine by CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease

Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease

Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response

Marijuana Use Among Adult Liver Transplant Candidates and Recipients

A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo

The Impact of Marijuana Use on Liver Transplant Recipients: A 900 Patient Single Center Experience

Epidemiology of cannabis use and associated outcomes among kidney transplant recipients: A meta-analysis

P-NGAL Day 1 predicts early but not one year graft function following deceased donor kidney transplantation - The CONTEXT study

Marijuana use should not preclude consideration for kidney transplantation

Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation

Cannabis Dependence or Abuse in Kidney Transplantation: Implications for Posttransplant Outcomes

Influence of history of cannabis smoking in selected donors on the outcomes of lung transplantation

Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges.

High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana

A CB2-Selective Cannabinoid Suppresses T-cell Activities and Increases Tregs and IL-10

Cannabis - the Israeli perspective

Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation.

Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.

Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury.

Effects of Cannabinoids on T-cell Function and Resistance to Infection.